Effects of Immunoregulatory Cytokines (IL-2, IL-7, and IL-15) on Expression of Gfi1 and U2afll4 Genes in T Cells at Different Stages of Differentiation

Verfasser / Beitragende:
[N. Sokhonevich, K. Yurova, A. Gutsol, O. Khaziakhmatova, I. Mazunin, L. Litvinova]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 159/2(2015-06-01), 236-239
Format:
Artikel (online)
ID: 605536473
LEADER caa a22 4500
001 605536473
003 CHVBK
005 20210128100852.0
007 cr unu---uuuuu
008 210128e20150601xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-2931-8  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-2931-8 
245 0 0 |a Effects of Immunoregulatory Cytokines (IL-2, IL-7, and IL-15) on Expression of Gfi1 and U2afll4 Genes in T Cells at Different Stages of Differentiation  |h [Elektronische Daten]  |c [N. Sokhonevich, K. Yurova, A. Gutsol, O. Khaziakhmatova, I. Mazunin, L. Litvinova] 
520 3 |a Opposite effects of common γ-chain cytokines (IL-2, IL-7, and IL-15) on the expression of Gfi1 and U2af1l4 genes regulating alternative splicing of Ptprc gene in T cells at different stages of differentiation were demonstrated in vitro. Generally, produced a dose-dependent activating effect on T cells, while to the effects of rIL-7 and rIL-15 on T cells at different stages of differentiation were opposite to that of rIL-2: maximum concentrations of recombinant cytokines IL-7 and IL-15 produced the most pronounced inhibitory effect on U2af1l4 and to a lesser extent on Gfi1 gene expression, thus limiting activation of resting cells. This is consistent with their biological effects on T cells. In general, common γ-chain cytokines IL-2, IL-7, and IL-15 prevent differentiation of naïve T cells in vitro and limit activation of primed T cells in the absence of antigenic stimulus, which can contribute to the formation of cytokine imbalance. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a cytokines  |2 nationallicence 
690 7 |a expression of Gfi1 and U2afll4 genes  |2 nationallicence 
690 7 |a memory T cells  |2 nationallicence 
690 7 |a naïve cells  |2 nationallicence 
690 7 |a alternative splicing  |2 nationallicence 
700 1 |a Sokhonevich  |D N.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
700 1 |a Yurova  |D K.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
700 1 |a Gutsol  |D A.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
700 1 |a Khaziakhmatova  |D O.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
700 1 |a Mazunin  |D I.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
700 1 |a Litvinova  |D L.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/2(2015-06-01), 236-239  |x 0007-4888  |q 159:2<236  |1 2015  |2 159  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-2931-8  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-2931-8  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sokhonevich  |D N.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yurova  |D K.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Gutsol  |D A.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Khaziakhmatova  |D O.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Mazunin  |D I.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Litvinova  |D L.  |u Laboratory of Immunology and Cell Technologies, Innovation Park, I. Kant Baltic Federal University, Kaliningrad, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/2(2015-06-01), 236-239  |x 0007-4888  |q 159:2<236  |1 2015  |2 159  |o 10517